logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

B. Savastano

universita della campania vanvitelli
H指数:5
被引数:261
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hematological Toxicity During Concomitant Treatment With Ruxolitinib and Avelumab for Merkel Cell Carcinoma

鲁索替尼和阿维鲁单抗联合治疗默克尔细胞癌期间的血液学毒性

FRONTIERS IN ONCOLOGY
IF3.3
2020-10-222
OAAI
Buonerba, Luciana; Di Trolio, Rossella; Grimaldi, Antonio; Tucci, Aniello; Leo, Emilio; Ingenito, Concetta; Costabile, Ferdinando; Ragone, Gianluca; Savastano, Beatrice; Uzzauto, Maria Teresa; Belsito Petrizzi, Valeria; Di Lorenzo, Giuseppe
Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?
FRONTIERS IN MEDICINE
IF3
2020-05-063
OAAI
Ingenito, Concetta; Buonerba, Luciana; Ferrara, Claudia; Busto, Giuseppina; Libroia, Annamaria; Ragone, Gianluca; Leo, Emilio; Savastano, Beatrice; Ioio, Concetta Dello; De Falco, Ferdinando; Iaccarino, Simona; Tarantino, Luciano; Polverino, Mario; Di Lorenzo, Giuseppe
Neutrophil to lymphocyte ratio is a predictor of outcome in metastatic pancreatic cancer patients (MPC) treated with nab-paclitaxel and gemcitabine
ANNALS OF ONCOLOGY
IF65.4
2016-10-010
OAAI
Ventriglia, J.; Petrillo, A.; Huerta, M.; Laterza, M. M.; Savastano, B.; Gambardella, V.; Tirino, G.; Pompella, L.; Diana, A.; Febbraro, A.; Troiani, T.; Orditura, M.; Cervantes, A.; Ciardiello, F.; De Vita, F.
Prognostic implications of baseline neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in metastatic gastric cancer (GC) patients
ANNALS OF ONCOLOGY
IF65.4
2016-10-011
OAAI
Petrillo, A.; Laterza, M. M.; Ventriglia, J.; Savastano, B.; Tirino, G.; Pompella, L.; Martinelli, E.; Morgillo, F.; Orditura, M.; Ciardiello, F.; De Vita, F.
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors
ANNALS OF ONCOLOGY
IF65.4
2016-10-010
OAAI
Savastano, B.; Della Corte, C. M.; Papaccio, F.; Giuseppe, V.; Esposito, G.; Fasano, M.; Orditura, M.; De Vita, F.; Ciardiello, F.; Morgillo, F.
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice
BMC CANCER
IF3.4
2016-09-0249
OAAI
De Vita, Ferdinando; Ventriglia, Jole; Febbraro, Antonio; Laterza, Maria Maddalena; Fabozzi, Alessio; Savastano, Beatrice; Petrillo, Angelica; Diana, Anna; Giordano, Guido; Troiani, Teresa; Conzo, Giovanni; Galizia, Gennaro; Ciardiello, Fortunato; Orditura, Michele
Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2 amplified gastric cancer (GC) cell lines
ANNALS OF ONCOLOGY
IF65.4
2016-09-010
OAAI
Laterza, M. M.; Belli, V.; Ciaramella, V.; Martinelli, E.; Morgillo, F.; Ventriglia, J.; Savastano, B.; Petrillo, A.; Tirino, G.; Pompella, L.; Diana, A.; Orditura, M.; Ciardiello, F.; De Vita, F.
GDC-0980, a novel PI3K/mTOR kinase inhibitor, is effective in HER2 positive gastric cancer (GC) cell lines resistant to Trastuzumab
ANNALS OF ONCOLOGY
IF65.4
2016-09-011
OAAI
Ventriglia, J.; Laterza, M. M.; Capasso, A.; Belli, V.; Savastano, B.; Petrillo, A.; Tirino, G.; Pompella, L.; Diana, A.; Orditura, M.; Ciardiello, F.; De Vita, F.
The combination of GDC-0980, a PI3K/mTOR kinase inhibitor and BAY-86-9766, a MEK inhibitor is able to induce cell growth inhibition of HER2 positive Trastuzumab resistant gastric cancer cell lines
ANNALS OF ONCOLOGY
IF65.4
2016-09-011
OAAI
Savastano, B.; Laterza, M. M.; Capasso, A.; Belli, V.; Ventriglia, J.; Petrillo, A.; Tirino, G.; Pompella, L.; Morgillo, F.; Martinelli, E.; Orditura, M.; Ciardiello, F.; De Vita, F.
Pancreatic neuroendocrine tumors: Nosography, management and treatment

胰腺神经内分泌肿瘤: 影像学，管理和治疗

INTERNATIONAL JOURNAL OF SURGERY
IF10.1
2016-04-0141
OAAI
Orditura, Michele; Petrillo, Angelica; Ventriglia, Jole; Diana, Anna; Laterza, Maria Maddalena; Fabozzi, Alessio; Savastano, Beatrice; Franzese, Elisena; Conzo, Giovanni; Santini, Luigi; Ciardiello, Fortunato; De Vita, Ferdinando
Baseline neutrophil-lymphocyte ratio as a prognostic factor for patients with resectable gastric cancer undergoing adjuvant chemotherapy
EUROPEAN JOURNAL OF CANCER
IF7.1
2015-09-010
PREAI
Laterza, M. M.; Petrillo, A.; Ventriglia, J.; Fabozzi, A.; Savastano, B.; Tirino, G.; Orditura, M.; Diana, A.; Ciardiello, F.; De Vita, F.
Baseline neutrophil-lymphocyte ratio as a prognostic factor for patients with resectable gastric cancer undergoing adjuvant chemotherapy
ANNALS OF ONCOLOGY
IF65.4
2015-06-010
OAAI
Laterza, M. M.; Petrillo, A.; Ventriglia, J.; Savastano, B.; Diana, A.; Tirino, G.; Martinelli, E.; Orditura, M.; Ciardiello, F.; de Vita, F.

研究方向

暂未获取到该数据
F
Fortunato Ciardiello
H 指数:107论文数:1,034被引数:6.4万
A
Angelica Petrillo
H 指数:24论文数:146被引数:1,883
M
Maria Maddalena Laterza
H 指数:13论文数:71被引数:774
J
Jole Ventriglia
H 指数:18论文数:66被引数:893
M
Michele Orditura
H 指数:54论文数:330被引数:9,203
A
Anna Diana
H 指数:22论文数:97被引数:1,727
G
Giuseppe Tirino
H 指数:14论文数:50被引数:582
F
Ferdinando De Vita
H 指数:54论文数:353被引数:1.0万
L
Luca Pompella
H 指数:12论文数:38被引数:526
F
Floriana Morgillo
H 指数:52论文数:394被引数:9,848